Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo

Xiao Heng Zhao, Franklin Chi Meng Tay, Yan Jun Fang, Liu Yan Meng, Zhuan Bian

Research output: Contribution to journalArticle

Abstract

Objectives: Gingival recession and alveolar bone loss are common manifestations of periodontitis. Periodontal regeneration is the ideal strategy for rehabilitating periodontal tissue defects and preventing tooth loss. The present study examined whether localized, topical application of gingival overgrowth-inducing drugs, phenytoin, nifedipine or cyclosporine, induces periodontal regeneration. Methods: Polylactic-co-glycolic acid (PLGA) was used as the carrier for preparation of phenytoin, nifedipine or cyclosporine-loaded PLGA microspheres, using an oil-in-water emulsification technique. The drug-loaded microspheres were delivered to periodontal defects created on alveolar ridges mesial to the first maxillary molars of Sprague-Dawley rats. After eight weeks, the operation area in each rat, including the maxillary molars and periodontal tissues, was harvested and evaluated by micro-computed tomography, histochemical and immunohistochemical analyses. Results: Physical parameters representative of periodontal regeneration, including the length of new alveolar bone (p < 0.01) and the area of new alveolar bone (p < 0.01) were significantly improved in the phenytoin group. Compared to other groups, the phenytoin group demonstrated increased expression of COL-1, VEGF-A, osteoblast and osteoclast markers (BMP-2, TGF-β1, OCN and TRAP staining), as well as decreased expression of MMP-8. Conclusions: Results of the present study provided new evidence that localized, controlled release of phenytoin confers therapeutic benefits toward gingival recession and alveolar bone loss. Phenytoin appears to be a promising drug that promotes periodontal regeneration.

LanguageEnglish (US)
Pages42-51
Number of pages10
JournalArchives of Oral Biology
Volume97
DOIs
StatePublished - Jan 1 2019

Fingerprint

glycolic acid
Phenytoin
Nifedipine
Microspheres
Regeneration
Gingival Recession
Alveolar Bone Loss
Cyclosporine
Gingival Overgrowth
Pharmaceutical Preparations
Alveolar Process
Bone and Bones
Tooth Loss
Periodontitis
Osteoclasts
Osteoblasts
Matrix Metalloproteinases
Vascular Endothelial Growth Factor A
Sprague Dawley Rats
Oils

Keywords

  • Alveolar bone loss
  • Anti-epileptics
  • Bone remodeling
  • Drug delivery
  • Gingival overgrowth

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Dentistry(all)
  • Cell Biology

Cite this

Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo. / Zhao, Xiao Heng; Tay, Franklin Chi Meng; Fang, Yan Jun; Meng, Liu Yan; Bian, Zhuan.

In: Archives of Oral Biology, Vol. 97, 01.01.2019, p. 42-51.

Research output: Contribution to journalArticle

@article{87e40803b7c14c258f11d5613deb0a41,
title = "Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo",
abstract = "Objectives: Gingival recession and alveolar bone loss are common manifestations of periodontitis. Periodontal regeneration is the ideal strategy for rehabilitating periodontal tissue defects and preventing tooth loss. The present study examined whether localized, topical application of gingival overgrowth-inducing drugs, phenytoin, nifedipine or cyclosporine, induces periodontal regeneration. Methods: Polylactic-co-glycolic acid (PLGA) was used as the carrier for preparation of phenytoin, nifedipine or cyclosporine-loaded PLGA microspheres, using an oil-in-water emulsification technique. The drug-loaded microspheres were delivered to periodontal defects created on alveolar ridges mesial to the first maxillary molars of Sprague-Dawley rats. After eight weeks, the operation area in each rat, including the maxillary molars and periodontal tissues, was harvested and evaluated by micro-computed tomography, histochemical and immunohistochemical analyses. Results: Physical parameters representative of periodontal regeneration, including the length of new alveolar bone (p < 0.01) and the area of new alveolar bone (p < 0.01) were significantly improved in the phenytoin group. Compared to other groups, the phenytoin group demonstrated increased expression of COL-1, VEGF-A, osteoblast and osteoclast markers (BMP-2, TGF-β1, OCN and TRAP staining), as well as decreased expression of MMP-8. Conclusions: Results of the present study provided new evidence that localized, controlled release of phenytoin confers therapeutic benefits toward gingival recession and alveolar bone loss. Phenytoin appears to be a promising drug that promotes periodontal regeneration.",
keywords = "Alveolar bone loss, Anti-epileptics, Bone remodeling, Drug delivery, Gingival overgrowth",
author = "Zhao, {Xiao Heng} and Tay, {Franklin Chi Meng} and Fang, {Yan Jun} and Meng, {Liu Yan} and Zhuan Bian",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.archoralbio.2018.10.002",
language = "English (US)",
volume = "97",
pages = "42--51",
journal = "Archives of Oral Biology",
issn = "0003-9969",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo

AU - Zhao, Xiao Heng

AU - Tay, Franklin Chi Meng

AU - Fang, Yan Jun

AU - Meng, Liu Yan

AU - Bian, Zhuan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: Gingival recession and alveolar bone loss are common manifestations of periodontitis. Periodontal regeneration is the ideal strategy for rehabilitating periodontal tissue defects and preventing tooth loss. The present study examined whether localized, topical application of gingival overgrowth-inducing drugs, phenytoin, nifedipine or cyclosporine, induces periodontal regeneration. Methods: Polylactic-co-glycolic acid (PLGA) was used as the carrier for preparation of phenytoin, nifedipine or cyclosporine-loaded PLGA microspheres, using an oil-in-water emulsification technique. The drug-loaded microspheres were delivered to periodontal defects created on alveolar ridges mesial to the first maxillary molars of Sprague-Dawley rats. After eight weeks, the operation area in each rat, including the maxillary molars and periodontal tissues, was harvested and evaluated by micro-computed tomography, histochemical and immunohistochemical analyses. Results: Physical parameters representative of periodontal regeneration, including the length of new alveolar bone (p < 0.01) and the area of new alveolar bone (p < 0.01) were significantly improved in the phenytoin group. Compared to other groups, the phenytoin group demonstrated increased expression of COL-1, VEGF-A, osteoblast and osteoclast markers (BMP-2, TGF-β1, OCN and TRAP staining), as well as decreased expression of MMP-8. Conclusions: Results of the present study provided new evidence that localized, controlled release of phenytoin confers therapeutic benefits toward gingival recession and alveolar bone loss. Phenytoin appears to be a promising drug that promotes periodontal regeneration.

AB - Objectives: Gingival recession and alveolar bone loss are common manifestations of periodontitis. Periodontal regeneration is the ideal strategy for rehabilitating periodontal tissue defects and preventing tooth loss. The present study examined whether localized, topical application of gingival overgrowth-inducing drugs, phenytoin, nifedipine or cyclosporine, induces periodontal regeneration. Methods: Polylactic-co-glycolic acid (PLGA) was used as the carrier for preparation of phenytoin, nifedipine or cyclosporine-loaded PLGA microspheres, using an oil-in-water emulsification technique. The drug-loaded microspheres were delivered to periodontal defects created on alveolar ridges mesial to the first maxillary molars of Sprague-Dawley rats. After eight weeks, the operation area in each rat, including the maxillary molars and periodontal tissues, was harvested and evaluated by micro-computed tomography, histochemical and immunohistochemical analyses. Results: Physical parameters representative of periodontal regeneration, including the length of new alveolar bone (p < 0.01) and the area of new alveolar bone (p < 0.01) were significantly improved in the phenytoin group. Compared to other groups, the phenytoin group demonstrated increased expression of COL-1, VEGF-A, osteoblast and osteoclast markers (BMP-2, TGF-β1, OCN and TRAP staining), as well as decreased expression of MMP-8. Conclusions: Results of the present study provided new evidence that localized, controlled release of phenytoin confers therapeutic benefits toward gingival recession and alveolar bone loss. Phenytoin appears to be a promising drug that promotes periodontal regeneration.

KW - Alveolar bone loss

KW - Anti-epileptics

KW - Bone remodeling

KW - Drug delivery

KW - Gingival overgrowth

UR - http://www.scopus.com/inward/record.url?scp=85054844676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054844676&partnerID=8YFLogxK

U2 - 10.1016/j.archoralbio.2018.10.002

DO - 10.1016/j.archoralbio.2018.10.002

M3 - Article

VL - 97

SP - 42

EP - 51

JO - Archives of Oral Biology

T2 - Archives of Oral Biology

JF - Archives of Oral Biology

SN - 0003-9969

ER -